Study shows better asthma relief from combo therapy

05/23/2007 | Forbes

New data shows AstraZeneca's combination asthma treatment Symbicort improved quality of life and satisfaction for patients better than the drug's two main ingredients do separately. Symbicort, recently approved for long-term use, is a combination of the inhaled corticosteroid budesonide and the beta agonist formoterol fumarate dehydrate.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN